Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma

Cisplatin is one of the chemotherapeutic drugs used for the management of oral carcinoma, in which combined therapies are estimated to exert superior therapeutic efficacy compared with monotherapy. It is known that poly(ADP-ribosyl)ation is implicated in a multiplicity of cellular activities, such a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomedicines
Hlavní autoři: Paterniti, Irene, Scuderi, Sarah Adriana, Casili, Giovanna, Lanza, Marika, Mare, Marzia, Giuffrida, Raffella, Colarossi, Cristina, Portelli, Marco, Cuzzocrea, Salvatore, Esposito, Emanuela
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8301366/
https://ncbi.nlm.nih.gov/pubmed/34356835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9070771
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky